Datamatics Global Services Reports Robust Q2 Growth with 49% Surge in Net Profit

1 min read     Updated on 30 Oct 2025, 05:56 PM
scanx
Reviewed by
Jubin VergheseScanX News Team
Overview

Datamatics Global Services posted robust Q2 FY2025-26 results with net profit rising 49.3% to ₹63.24 crore. Revenue increased by 20.5% to ₹490.23 crore, while EBITDA grew 82.1% to ₹88.80 crore. EBITDA margin expanded to 18.12% from 11.99%. The company's performance was driven by growth across its three main business segments: Digital Operations (₹272.48 crore), Digital Technologies (₹153.13 crore), and Digital Experiences (₹64.62 crore). Datamatics maintained a strong balance sheet with total assets of ₹2,154.06 crore and cash equivalents of ₹127.98 crore as of September 30, 2025.

23372820

*this image is generated using AI for illustrative purposes only.

Datamatics Global Services has reported a strong financial performance for the second quarter of fiscal year 2025-26, with significant growth across key metrics.

Financial Highlights

Metric (₹ crore) Q2 FY2025-26 Q2 FY2024-25 YoY Change
Revenue 490.23 406.75 +20.5%
EBITDA 88.80 48.76 +82.1%
EBITDA Margin 18.12% 11.99% +613 bps
Net Profit 63.24 42.36 +49.3%

The company's consolidated net profit for the quarter ended September 30, 2025, rose to ₹63.24 crore from ₹42.36 crore in the corresponding quarter of the previous year, marking a substantial 49.3% increase. This growth was supported by a 20.5% year-over-year rise in revenue, which reached ₹490.23 crore compared to ₹406.75 crore in the same period last year.

Operational Performance

Datamatics witnessed a remarkable improvement in its operational efficiency, with EBITDA surging to ₹88.80 crore from ₹48.76 crore in the year-ago quarter. The EBITDA margin expanded significantly to 18.12% from 11.99%, reflecting enhanced profitability and operational excellence.

Segment-wise Performance

The company's performance was driven by growth across its three main business segments:

  1. Digital Operations: Emerged as the largest revenue contributor with ₹272.48 crore.
  2. Digital Technologies: Generated revenue of ₹153.13 crore.
  3. Digital Experiences: Contributed ₹64.62 crore to the total revenue.

Balance Sheet Strength

As of September 30, 2025, Datamatics maintained a robust balance sheet with total assets of ₹2,154.06 crore. The company's financial position remains strong with a healthy cash and cash equivalents balance of ₹127.98 crore.

Management Commentary

While specific management comments were not provided in the financial release, the significant improvement in profitability and margins suggests that the company's strategic initiatives and focus on high-value digital services are yielding positive results.

Future Outlook

The company's consistent performance and growth across segments indicate a positive outlook. However, Datamatics has not provided specific forward-looking statements or guidance for the upcoming quarters.

Investors and analysts will likely look forward to the company's future communications for insights into its growth strategy, potential market expansions, and initiatives to maintain the current growth momentum in an evolving digital landscape.

Datamatics Global Services continues to demonstrate its resilience and adaptability in the dynamic IT services market, as reflected in its strong quarterly performance.

Historical Stock Returns for Datamatics Global Services

1 Day5 Days1 Month6 Months1 Year5 Years
+0.77%+9.48%+16.62%+65.18%+68.33%+1,245.01%
Datamatics Global Services
View in Depthredirect
like16
dislike

Datamatics Partners with Well Pharmacy to Revolutionize Medication Record Management

1 min read     Updated on 14 Oct 2025, 12:10 PM
scanx
Reviewed by
Naman SharmaScanX News Team
Overview

Datamatics Global Services Limited has partnered with Well Pharmacy, the UK's largest independent pharmacy chain, to modernize medication record-keeping for care home patients. The long-term contract involves implementing Datamatics' AI-powered automation platforms, TruCap+ and TruBot, to automate the Medication Administration Record (MAR) process. This initiative aims to enhance accuracy, improve efficiency, reduce costs, and increase productivity in managing patient records. Well Pharmacy plans to scale this solution to support over 70,000 patients in care homes, significantly impacting the UK's healthcare landscape.

21969663

*this image is generated using AI for illustrative purposes only.

Datamatics Global Services Limited , a leader in digital technologies, has announced a significant partnership with Well Pharmacy, the UK's largest independent pharmacy chain. This collaboration aims to modernize medication record-keeping for patients in care homes, leveraging Datamatics' AI-powered automation platforms.

Partnership Details

Well Pharmacy, operating over 650 pharmacies across the UK with an annual revenue of approximately £800 million, has signed a long-term contract with Datamatics. The partnership will focus on automating the Medication Administration Record (MAR) process, utilizing Datamatics' intelligent automation products:

  • TruCap+: For Intelligent Document Processing (IDP)
  • TruBot: For Robotic Process Automation (RPA)

Automation Benefits

The implementation of these AI-powered platforms is expected to bring several advantages:

Benefit Description
Enhanced Accuracy Minimizes manual errors in patient records
Improved Efficiency Automates updates and reduces manual effort
Cost Reduction Lowers manual effort and reduces wastage
Scalability Manages varied prescription formats at high volumes
Increased Productivity Allows pharmacists and care teams to focus more on patient care

Scope and Impact

The automation initiative aims to create reliable Monitored Dosage System (MDS) records while enhancing patient safety. Well Pharmacy plans to scale this solution to support over 70,000 patients in care homes, significantly impacting the UK's healthcare landscape.

Strategic Importance

This partnership reinforces Datamatics' position in the global healthcare sector. Notably, Datamatics' Intelligent Automation platform is already empaneled by NHS Shared Business Services in the UK, highlighting its growing influence in the healthcare industry.

Andrew Caplan, Chief Retail Officer from Well Pharmacy, emphasized the critical nature of accuracy in the medical industry and how this partnership provides a flexible, easy-to-use solution ensuring precision while simplifying complex processes.

Mitul Mehta, Chief Marketing Officer at Datamatics, expressed excitement about the partnership, stating, "With our experience in the Healthcare industry, we are confident to deliver the desired benefits of automation including accuracy, efficiency and process compliance."

This collaboration between Datamatics and Well Pharmacy represents a significant step forward in the digital transformation of healthcare services, promising to enhance patient care through innovative technology solutions.

Historical Stock Returns for Datamatics Global Services

1 Day5 Days1 Month6 Months1 Year5 Years
+0.77%+9.48%+16.62%+65.18%+68.33%+1,245.01%
Datamatics Global Services
View in Depthredirect
like19
dislike
More News on Datamatics Global Services
Explore Other Articles
977.15
+7.45
(+0.77%)